This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

European Commission targets alleged ‘pay-for-delay’ with pharma fines


The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs. 

Lundbeck, EPO, European Commission, citalopram


Payment types accepted